Brand-name GLP-1 medications like Ozempic are not FDA-approved for IBS treatment, though emerging research suggests they may help some IBS patients through their effects on gut motility and visceral sensitivity
Listed Products of GLP-1 Receptor Agonists (GLP-1RA) At present, 9 GLP-1 receptor agonist hypoglycemic drugs have been approved for marketing in the world, namely: exenatide, liraglutide, Exenatide extended-release (exenatide ER), albiglutide, dulaglutide , lixisenatide, benaglutide, semaglutide, polyethylene glycol loxenatide injection and oral semaglutide
Animal studies show the medication concentrates in mammary tissue, suggesting potential transfer to breast milk
The organization also warns that since its not approved for human clinical use by any global regulatory authority, it may lead to negative health effects including immunogenic reactions (antibodies), peptide impurities, and limited safety data for proposed routes of use